Chengdu Easton Biopharmaceuticals Co., Ltd. Share Price
Equities
688513
CNE100004397
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
60.58 CNY | +0.71% | +4.61% | -5.02% |
Sales 2024 * | 1.45B 201M 16.75B | Sales 2025 * | 1.77B 245M 20.4B | Capitalization | 7.21B 996M 83.04B |
---|---|---|---|---|---|
Net income 2024 * | 291M 40.19M 3.35B | Net income 2025 * | 362M 50M 4.17B | EV / Sales 2024 * | 4.96 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.07 x |
P/E ratio 2024 * |
25
x | P/E ratio 2025 * |
20.1
x | Employees | 1,400 |
Yield 2024 * |
1.25% | Yield 2025 * |
1.5% | Free-Float | 45.41% |
1 day | +0.71% | ||
1 week | +4.61% | ||
Current month | +5.85% | ||
1 month | +5.85% | ||
3 months | +18.25% | ||
6 months | +11.98% | ||
Current year | -5.02% |
Managers | Title | Age | Since |
---|---|---|---|
Ming Xu Yuan
CEO | Chief Executive Officer | 53 | 01/09/01 |
Ying Wang
FOU | Founder | 58 | 01/09/01 |
Jia Yu Zhu
CHM | Chairman | 44 | 01/09/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Wu Geng
BRD | Director/Board Member | 56 | 23/21/23 |
Ying Wang
FOU | Founder | 58 | 01/09/01 |
Da Ming Zhang
BRD | Director/Board Member | 52 | 01/09/01 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 60.58 | +0.71% | 574,704 |
29/24/29 | 60.15 | +4.35% | 844,075 |
26/24/26 | 57.64 | -3.17% | 823,828 |
25/24/25 | 59.53 | +0.30% | 458,844 |
24/24/24 | 59.35 | -1.05% | 391,024 |
End-of-day quote Shanghai S.E., April 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.02% | 996M | |
+29.68% | 681B | |
+20.34% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.32% | 235B | |
+4.36% | 199B | |
-11.49% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- 688513 Stock